Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 7:27:100906.
doi: 10.1016/j.conctc.2022.100906. eCollection 2022 Jun.

Pilot study of autologous fecal microbiota transplants in nursing home residents: Feasibility and safety

Affiliations

Pilot study of autologous fecal microbiota transplants in nursing home residents: Feasibility and safety

Christine K Liu et al. Contemp Clin Trials Commun. .

Abstract

Introduction: Antibiotic resistant bacterial infections (ARBIs) are extremely common in nursing home residents. These infections typically occur after a course of antibiotics, which eradicate both pathological and beneficial organisms. The eradication of beneficial organisms likely facilitates subsequent ARBIs. Autologous fecal microbiota transplant (aFMT) has been proposed as a potential treatment to reduce ARBIs in nursing home residents. Our objective was to determine the feasibility and safety of aFMT in a nursing home population.

Methods: Pilot clinical trial. We evaluated feasibility as total number of stool samples collected for aFMT production and safety as the number and relatedness of serious (SAE) and non-serious adverse events (AE).

Results: We screened 468 nursing home residents aged ≥18 years for eligibility; 67 enrolled, distributed among three nursing homes. Participants were 62.7% female and 35.8% Black. Mean age was 82.2 ± 8.5 years. Thirty-three participants underwent successful stool collection. Seven participants received antibiotics; four participants underwent aFMT. There were 40 SAEs (17 deaths) and 11 AEs. In the aFMT group, there were 3 SAEs (2 deaths) and 10 AEs. All SAEs and AEs were judged unrelated to the study intervention.

Conclusions: In this pilot study of aFMT in nursing home residents, less than half were able to provide adequate stool samples for aFMT. There were no related SAEs or AEs during the study. In sum, we conclude aFMT has limited feasibility in a nursing home population due to logistic and technical challenges but is likely safe.

Trial registration: ClinicalTrials.gov Identifier: NCT03061097.

Keywords: AE, adverse event; ARBI, antibiotic resistant bacterial infections; Elderly; FMT, fecal microbiota transplant; Fecal transplants; Microbiota; Nursing home; Older adults; SAE, serious adverse event; aFMT, autologous fecal microbiota transplant.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Shrish Budree is a shareholder and employee of Finch Therapeutics. Zain Kassam is a shareholder of Finch Therapeutics.

Figures

Fig. 1
Fig. 1
CONSORT diagram of study.

Similar articles

Cited by

References

    1. Pamer E.G. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016;352:535–538. doi: 10.1126/science.aad9382. 80. - DOI - PMC - PubMed
    1. Kelly C.R., Yen E.F., Grinspan A.M., Kahn S.A., Atreja A., Lewis J.D., et al. Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry. Gastroenterology. 2021;160:183–192. doi: 10.1053/j.gastro.2020.09.038. e3. - DOI - PMC - PubMed
    1. Relman D.A. The human microbiome: ecosystem resilience and health. Nutr. Rev. 2012;70 doi: 10.1111/j.1753-4887.2012.00489.x. - DOI - PMC - PubMed
    1. Becattini S., Taur Y., Pamer E.G. Antibiotic-induced changes in the intestinal microbiota and disease. Trends Mol. Med. 2016;22:458–478. doi: 10.1016/j.molmed.2016.04.003. - DOI - PMC - PubMed
    1. Hentges D.J., Freter R. In vivo and in vitro antagonism of intestinal bacteria against shigella flexneri i. correlation between various tests. J. Infect. Dis. 1962;110:30–37. doi: 10.1093/infdis/110.1.30. - DOI - PubMed

Associated data